Weiss Multi Strategy Advisers LLC Galera Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.08 - $10.44 $161,563 - $277,422	-26,573 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$8.35 - $12.39 $35,195 - $52,223	-4,215 Reduced 13.69%	26,573 $234,000
Q4 2020 Feb 16, 2021	SELL	$8.02 - $12.81 $297,012 - $474,405	-37,034 Reduced 54.6%	30,788 $315,000
Q3 2020 Nov 16, 2020	BUY	$6.96 - $9.12 $110,121 - $144,296	15,822 Added 30.43%	67,822 $613,000
Q2 2020 Aug 14, 2020	BUY	$7.14 - $14.41 $25,047 - $50,550	3,508 Added 7.23%	52,000 $371,000

Q1 2020 May 15, 2020	SELL	$5.89 - $17.67 $67,782 - $203,346	-11,508 Reduced 19.18%	48,492 $461,000
Q4 2019 Feb 14, 2020	BUY	$9.13 - $13.9 $547,800 - $834,000	60,000 New	60,000 $790,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.